Office-Based Intralesional Steroid Injection for Treatment of Laryngeal Sarcoidosis.

xlomafota13 shared this article with you from Inoreader Office-Based Intralesional Steroid Injection for Treatment of Laryngeal Sarcoidosis. Via otol rhinol Related Articles Office-Based Intralesional Steroid Injection for Treatment of Laryngeal Sarcoidosis. Ann Otol Rhinol Laryngol. 2021 Feb 15;:3489421995287 Authors: Farlow JL, Park JV, Morrison RJ, Kupfer RA Abstract OBJECTIVES: To report preliminary outcomes of a case series of in-office intralesional steroid injections for treatment of laryngeal sarcoidosis. METHODS: After diagnosis of laryngeal sarcoidosis, 3 patients were offered in-office steroid injections for primary or adjunctive treatment. Triamcinolone 40 was injected into supraglottic sarcoidosis lesions in the office using a channel laryngoscope. Response to treatment and need for further injections was determined based on patient symptoms and repeat flexible laryngoscopy. RESULTS: In-office intralesional steroid injections provided rapid symptom relief within days that lasted for months, thus decreasing the frequency of operative interventions. For one of the patients in this series, these injections even eliminated the need for tracheostomy. No complications were observed. CONCLUSIONS: In-office intralesional steroid injection is an emerging adjunctive treatment for laryngeal sarcoidosis. Prospective studies are required to determine efficacy and long-term risk profiles in relation to the current standard of operative management and systemic treatments. PMID: 33583192 [PubMed - as supplied by publisher] View on the web Inoreader. Take back control of your news feed. Follow us on Twitter and Facebook.